The researchers now plan to incorporate their new tool into a drug development program, leading to early clinical trials.

The project is a part of Adnoc’s P5 production enhancement plan ... two people close to the bid process told Upstream. Those said to be preparing bids include China Petroleum Engineering ...

Adnoc Gas has kicked off an early engagement process for selecting leading ... to handle additional associated gas production at other key facilities, Upstream reported. The first package includes ...

Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, is collaborating with Cytiva, a global life sciences leader, to provide customers with an integrated ...

Synopsys (SNPS) announced a broad Electronic Design Automation, or EDA, and Intellectual Property collaboration with Intel ...

Intel Foundry Direct Connect 2025 took place this week in San Jose, California, and the company reported progress on its ...

This innovative process ... production process, ADMA continues to demonstrate its leadership in modernizing and advancing plasma fractionation through agile, forward-thinking scientific ...

This is an important study utilizing innovative CRISPR based approaches demonstrating the role of the KLF family of transcription factors in the post natal maturation of cortical projection neurons.

(RTTNews) - ADMA Biologics, Inc. (ADMA) Monday said that the United States Food and Drug Administration (FDA) has approved the company's innovative production yield enhancement process. The ...

"As the first U.S. producer of plasma-derived products to achieve regulatory approval for its innovative yield enhancement production ... thinking scientific development and execution. We commend our ...

margin expansion and production output capacity as a result of FDA approval of the yield enhancement process, and timing related thereto, and our R&D platform. Actual events or results may differ ...

Preclinical Development of an AAV-delivered Zinc Finger Transcriptional Repressor Targeting the Prion Gene as a Novel Epigenetic Gene Therapy for Prion Disease Abstract No. 389 Oral Presentation ...